USP22 stabilizes c-Myc by removing the poly-ubiquitin chains and antagonizing the ubiquitination activity of its E3 ligase, FBW7, and consequently promoting breast cancer cell growth [8]. The gene discussed is MYC; the disease is breast carcinoma.